Follow The Filings

VRCA Verrica Pharmaceuticals

Verrica Pharmaceuticals earnings company data as of 4:48 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by VRCA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VRCA insider trades
  • $18.2M bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. David Zawitz COO
    Buy
    $30K 6,000 shares at $4.98 +29% to stake
    Traded Aug 17 Filed Aug 18
    ↗
  2. Jayson Rieger CEO
    Buy
    $126K 25,000 shares at $5.03 +14% to stake
    Traded Aug 14–17 Filed Aug 18
    ↗
  3. Noah L. Rosenberg CMO
    Buy
    $31K 6,230 shares at $4.91 +264% to stake
    Traded Aug 17–18 Filed Aug 18
    ↗
  4. John J. Kirby CFO
    Buy
    $25K 5,000 shares at $4.93 +26% to stake
    Traded Aug 18 Filed Aug 18
    ↗
  5. David Zawitz COO
    Buy
    $42K 10,000 shares at $4.24 +91% to stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
    ↗
  6. Jayson Rieger CEO
    Buy
    $400K 94,311 shares at $4.24 +107% to stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
    ↗
  7. Noah L. Rosenberg CMO
    Buy
    $10,000 2,357 shares at $4.24 New stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
    ↗
  8. John J. Kirby CFO
    Buy
    $15K 3,536 shares at $4.24 +65% to stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
    ↗
  9. Paul B Manning Director
    Buy
    $17.5M 4,126,142 shares at $4.24
    Traded Nov 25, 2025 Filed Nov 25, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.02 Filing Doc
424B3 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D — Filing Doc
8-K 1.01,3.02,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.